EGFR S768I (DBCOND0151899)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT06517953 Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations treatment 2 recruiting NCT05548348 First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation treatment 2 recruiting